BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33581847)

  • 1. A cost-effectiveness analysis of three approaches for lymph node assessment in patients with low- and intermediate-risk endometrial cancer.
    Burg LC; Vermeulen RJ; Bekkers RLM; Wijn SRW; Rovers MM; Govers TM; Zusterzeel PLM
    Gynecol Oncol; 2021 Apr; 161(1):251-260. PubMed ID: 33581847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis.
    Suidan RS; Sun CC; Cantor SB; Mariani A; Soliman PT; Westin SN; Lu KH; Giordano SH; Meyer LA
    Obstet Gynecol; 2018 Jul; 132(1):52-58. PubMed ID: 29889752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
    Casarin J; Multinu F; Tortorella L; Cappuccio S; Weaver AL; Ghezzi F; Cilby W; Kumar A; Langstraat C; Glaser G; Mariani A
    Int J Gynecol Cancer; 2020 Jan; 30(1):41-47. PubMed ID: 31780567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis.
    McCann GA; Cohn DE; Jewell EL; Havrilesky LJ
    Gynecol Oncol; 2015 Feb; 136(2):300-4. PubMed ID: 25478927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
    Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
    Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study.
    Bogani G; Papadia A; Buda A; Casarin J; Di Donato V; Gasparri ML; Plotti F; Pinelli C; Paderno MC; Lopez S; Perrone AM; Barra F; Guerrisi R; Brusadelli C; Cromi A; Ferrari D; Chiapp V; Signorelli M; Leone Roberti Maggiore U; Ditto A; Palaia I; Ferrero S; De Iaco P; Angioli R; Panici PB; Ghezzi F; Landoni F; Mueller MD; Raspagliesi F
    Gynecol Oncol; 2021 Apr; 161(1):122-129. PubMed ID: 33485641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node sampling versus full lymphadenectomy in endometrial cancer: a SEER database analysis.
    Nahshon C; Kadan Y; Lavie O; Ostrovsky L; Segev Y
    Int J Gynecol Cancer; 2023 Oct; 33(10):1557-1563. PubMed ID: 37487660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-operative assessment of sentinel lymph node status by one-step nucleic acid amplification assay (OSNA) in early endometrial cancer: a prospective study.
    Monterossi G; Buca D; Dinoi G; La Fera E; Zannoni GF; Spadola S; Scambia G; Fanfani F
    Int J Gynecol Cancer; 2019 Jul; 29(6):1016-1020. PubMed ID: 31175137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
    Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancer.
    Dioun S; Chen L; Melamed A; Gockley A; St Clair CM; Hou JY; Khoury-Collado F; Hershman DL; Wright JD
    BJOG; 2022 Aug; 129(9):1591-1599. PubMed ID: 34962708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping followed by lymphadectomy and sentinel node mapping alone: Long-term results of a propensity-matched analysis.
    Bogani G; Casarin J; Leone Roberti Maggiore U; Ditto A; Pinelli C; Dell'acqua A; Lopez S; Chiappa V; Brusadelli C; Guerrisi R; Ferrero S; Ghezzi F; Raspagliesi F
    Gynecol Oncol; 2020 Jul; 158(1):77-83. PubMed ID: 32389376
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges.
    Stewart KI; Eska JS; Harrison RF; Suidan R; Abraham A; Chisholm GB; Meyer LA; Westin SN; Fleming ND; Frumovitz M; Aloia TA; Soliman PT
    Int J Gynecol Cancer; 2020 Mar; 30(3):352-357. PubMed ID: 31911539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is selective lymphadenectomy more cost-effective than routine lymphadenectomy in patients with endometrial cancer?
    Clements AE; Tierney BJ; Cohn DE; Straughn JM
    Gynecol Oncol; 2013 Feb; 128(2):166-70. PubMed ID: 23078763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer.
    Bjørnholt SM; Sponholtz SE; Mogensen O; Bouchelouche K; Parner ET; Neumann G; Jochumsen KM; Hamid BH; Davidsen MB; Bjørn SF; Dahl K; Jensen PT
    Gynecol Oncol; 2023 Apr; 171():121-128. PubMed ID: 36893488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node mapping in endometrial cancer after 2020 ESGO-ESTRO-ESP consensus update: what will happen in the next few years?
    Barczynski B; Fraszczak K; Bednarek W
    Ginekol Pol; 2022; 93(4):321-328. PubMed ID: 35156700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
    Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
    Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.